Pharmaceutical Technology Europe-08-01-2014

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Pharmaceutical manufacturers will be-and are already&mdashfacing enormous challenges to implement the serialization regulations within the given timeframe.

Pharmaceutical Technology Europe

Single-use technologies, which started off as a tool for small-volume solution storage and transport has now become the central, enabling technology around which manufacturing processes and facilities are being designed.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

In the past 10 years, safety issues have become increasingly important in pharmaceutical packaging, from needle sticking safety to counterfeit protection.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Single-use technologies have gained broad acceptance in biomanufacturing within the past few years, supporting flexible and cost-effective clinical production.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

New chemical entities with poor aqueous solubility require the use of technologies to enable sufficient oral bioavailability of these NCEs following administration.

Pharmaceutical Technology Europe

Developments in chromatography column technology to deliver greater efficiency, speed and inertness benefit the drug development process from discovery to manufacturing and quality control.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Film coating for solid oral dosage forms provide important patient benefits while enhancing brand recognition and adding value to innovator, generic, over-the-counter and nutritional products.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

With a number of branded biologics hanging at the patent cliff, the future looks promising for biosimilars.

Pharmaceutical Technology Europe

The success of new biopharmaceutical drugs also relies on innovative solutions such as single-use technologies that suppliers have to offer to the pharmaceutical industry.

Pharmaceutical Technology Europe

IPEC Europe continues to promote the quality, safety and functionality of excipients used in pharmaceutical products.

Pharmaceutical Technology Europe

Innovative therapeutic approaches beyond mAbs will require new methods for future facility construction.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Tool coatings are now seen as an acceptable means of solving production problems, such as sticking and corrosion, resulting in increased product yield.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Quality by design, process analytical technology, and high throughput screening have helped drive progress in pharmaceutical development.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Experts discuss developments and future trends in prefilled syringes.

Pharmaceutical Technology Europe

The European Union has developed a system for evaluating, approving and monitoring the safety of medicines that has also encouraged innovation.

Pharmaceutical Technology Europe

Single use has introduced a level of flexibility into facilities that was either unheard of or very expensive in a stainless-steel environment.

Pharmaceutical Technology Europe

Quality by Design has initiated a paradigm shift in solid dose pharmaceutical manufacturing.

Pharmaceutical Technology Europe
Industry Insider

August 01, 2014

A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Efforts to tackle challenges in tablet manufacture are shaped by quality by design (QbD) and continuous manufacturing.

Pharmaceutical Technology Europe

Global harmonisation would help improve supply-chain security and reduce the flow of falsified and sub-standard medicine into Europe.

Pharmaceutical Technology Europe

Continuous manufacturing is key to the future of pharmaceutical manufacturing.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

To realise the full potential for biosimilars, stakeholders must build a better understanding of biosimilars and to take a comprehensive view of how these important medicines can fit into treatment pathways.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies.

Pharmaceutical Technology Europe

The EXCiPACT Certification Scheme ensures patient safety through supplier quality while minimising the audit burden and overall costs for assessing the excipient supply chain.

Pharmaceutical Technology Europe

A breach in the pharmaceutical supply chain is only the tip of the iceberg.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Softgels are now being recognised as one of the preferred dosage forms for the treatment of pain, eye conditions, cough and cold, as well as allergy.

Pharmaceutical Technology Europe
Special Features

August 01, 2014

Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years.

Pharmaceutical Technology Europe

Pharmaceutical Technology Europe marks its 25th anniversary.

Pharmaceutical Technology Europe

A diverse range of particle sizing solutions is available, from techniques for the characterization of complex formulations through to online PAT tools for real-time measurement.

Issue PDF
Pharmaceutical Technology Europe

August 01, 2014

Click the title above to open the Pharmaceutical Technology Europe August 2014 issue in an interactive PDF format.